The Moroccan pharmaceutical group Sothema has taken a strategic step in diversifying its therapeutic offerings by forming a new partnership with Naali, a brand specializing in saffron‑based dietary supplements. The agreement was announced at the Officine Expo 2026 in Marrakech, a major annual event for professionals in the pharmaceutical industry.

Under this strategic collaboration, Sothema will be responsible for marketing Naali’s range of products, leveraging its extensive industrial expertise, well‑established distribution network, and regional presence to broaden the reach of these innovative solutions.

Founded in 2020, Naali quickly distinguished itself in the supplements market with a scientific approach to extracting key active compounds from saffron, such as safranal and crocin. These natural ingredients are known for their positive effects on mental health and overall well‑being, particularly in emotional balance and women’s health.

By integrating Naali’s products into its portfolio, Sothema reinforces its strategy of therapeutic diversification, which emphasizes innovation, scientific rigor, and responding to evolving health needs. This partnership is expected to open new growth opportunities for both companies, as Naali benefits from Sothema’s structured distribution channels both in Morocco and abroad.